Core Insights - Quantum Secure Encryption Corp (QSE) has launched qREK, a Software Development Kit (SDK) aimed at integrating post-quantum-resilient encryption into applications and systems [1][3][10] - qREK allows organizations to locally generate encryption keys using secure quantum-grade entropy, enhancing security by eliminating risks associated with cloud or remote key generation [2][7] - The launch of qREK represents a significant step in QSE's mission to modernize security measures in anticipation of vulnerabilities posed by quantum computing [3][5] Product Features - qREK enables local key generation on the client's machine, ensuring that cryptographic keys are never transmitted or exposed [7][9] - The SDK is compatible with existing cryptographic systems, including AES, RSA, and NIST-recommended post-quantum cryptography algorithms like Kyber and Dilithium [7][9] - qREK operates on a zero-trust architecture, allowing organizations to maintain control over their cryptographic lifecycle while utilizing next-generation quantum entropy [2][9] Market Positioning - QSE positions qREK as a transformative tool for developers and security teams, facilitating the integration of quantum-resilient encryption without disrupting existing workflows [6][8] - The company emphasizes the importance of qREK in preparing organizations for the post-quantum era, addressing the inadequacies of legacy key generation methods [5][6] - QSE's offerings, including qREK, aim to empower organizations to secure their data against current and future threats, thereby advancing global data security standards [10]

Core Insights - Zephyr Minerals Ltd. has engaged Pinyon Environmental, Inc. to conduct a comprehensive water monitoring program to support the resubmission of a mining permit application for its Dawson Gold Property in Colorado, with monitoring set to begin this month and continue quarterly until December 2026 [1] Company Developments - Ms. Suzan Frazer has retired as corporate secretary after serving since the company's inception in 2010, with Mr. David Felderhof succeeding her [2] Dawson Gold Property Overview - The Dawson Gold Deposit has an Inferred Mineral Resource of 343,000 tonnes grading 12.11 g/t for 133,500 ounces of gold at a 5 g/t cut-off, and 116,300 ounces at 10.55 g/t with a 40 g/t top cut, with the estimate effective as of July 19, 2013 [3] - A Preliminary Economic Assessment (PEA) from March 21, 2017, indicated robust economics with an all-in sustaining cost (AISC) of $692 per ounce, based on a gold price of $1,250/oz [3] - The project has significant exploration potential, particularly at depth and along the 700-metre-long Sentinel zone, which has not been drill tested [3] - The Dawson project benefits from a small footprint for the proposed underground mine, ownership of necessary lands, a favorable climate for year-round operations, and nearby infrastructure [3] Company Strategy - Zephyr Minerals is focused on obtaining a mining permit for the Dawson Gold property and advancing the project to the next development stage [4] - The company is also awaiting the Zimbabwean Government's decision on two Exclusive Prospecting Orders covering 124,000 hectares, which are prospective for gold and lithium [4]

Company Overview - Northern Graphite Corporation is the only flake graphite producing company in North America, focused on becoming a world leader in natural graphite production and upgrading it into high-value products critical to the green economy [3] - The company operates the Lac des Iles mine in Quebec, plans to increase output to meet growing demand from industrial customers and North American battery makers, and owns the advanced stage Bissett Creek graphite project in Ontario and the Okanjande graphite mine in Namibia [3] Stock Options Grant - The company has granted a total of 2,860,000 stock options to its Non-Executive Directors, which will vest immediately, are exercisable at $0.20 per share, and will expire on December 5, 2030 [1] - This stock option grant is intended to recognize the efforts of the Board and their confidence in the long-term value being built by the company [2]

Core Insights - Viscount Mining Corp. has reported significant advancements in its exploration program at the Passiflora copper-gold porphyry, indicating a large, district-scale porphyry system beneath the Passiflora corridor [2][3][4] Exploration Results - The integration of new MMI soil geochemistry with various datasets, including airborne imagery and Quantec MT geophysics, has strengthened the interpretation of the porphyry system [2][4][7] - A well-defined copper-in-soil trend has been outlined, remaining open to the west and north, which aligns with high conductivity features indicative of a deep intrusive center [4][5] - Elevated gold-in-soil values have been found overlapping with the copper trend, suggesting the presence of mineralized porphyry centers [5][19] Upcoming Drilling Plans - A drill plan has been established targeting both shallow USGS-mapped breccia pipes and deeper porphyry centers, with drilling expected to commence in early 2026 [8][20] - The next deep drill hole will test the strongest portion of the Quantec MT anomaly, which extends approximately 1500 meters deep [9][13] Historical Context - Historical mine records from 1908-1968 indicate a polymetallic enrichment in the region, with past shipments showing grades of approximately 10-15% lead and 5-15 oz/ton silver [14] - Recent drilling by Viscount has intersected 843.9 meters of continuous copper-gold mineralization, suggesting proximity to a larger intrusive system [28]

Core Viewpoint - OS Therapies has successfully completed a pre-Marketing Authorisation Application meeting with the UK MHRA for its Phase 2b clinical trial of OST-HER2, aimed at preventing or delaying recurrent pulmonary metastatic osteosarcoma [2][4] Group 1: Clinical Trial and Regulatory Progress - The company achieved full alignment on key points regarding non-clinical, chemistry, manufacturing, and controls (CMC), and post-market authorization confirmatory study design during the pre-MAA meeting [6] - The company plans to submit a conditional MAA for the Metastatic Osteosarcoma Program to the MHRA by the end of January 2026 [4][6] - A meeting with the US FDA is scheduled for December 11, 2025, to discuss biomarker data analysis, which is crucial for supporting a Biologics Licensing Application under the Accelerated Approval Program [3][6] Group 2: Clinical Efficacy and Future Plans - The Phase 2b clinical trial of OST-HER2 demonstrated statistically significant benefits in the 12-month event-free survival primary endpoint [7] - The company anticipates submitting a Biologics Licensing Application to the US FDA for OST-HER2 in osteosarcoma in the first quarter of 2026, which could lead to eligibility for a Priority Review Voucher [7] - OST-HER2 has received various designations from the US FDA, including Rare Pediatric Disease Designation and Fast-Track designation, indicating its potential significance in treating osteosarcoma [5][7] Group 3: Product Development and Innovation - OS Therapies is advancing its next-generation Antibody Drug Conjugate (ADC) and Drug Conjugates (DC), known as tunable ADC (tADC), utilizing proprietary technology for enhanced delivery of therapeutic payloads [8]

Vancouver, British Columbia--(Newsfile Corp. - December 9, 2025) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") is pleased to provide an update on its exploration activities across its portfolio of projects in Quebec, Ontario, Manitoba, Saskatchewan, New Brunswick, and Alaska, including partnerships with Sumitomo Metal Mining Canada Ltd. ("Sumitomo") and Centerra Gold Inc. ("Centerra").As of October 31, 2025, the Company's working capital position was approx ...

Core Insights - Valkea Resources Corp. has announced positive drill results from its 2025 fall exploration program at the Paana project in Finland, specifically targeting the Koivu Zone, indicating substantial bulk-tonnage gold potential [1][3][4] Drill Program Overview - The fall 2025 drill program consisted of 2,454 meters of core drilling across seven holes, focusing on the up-dip and strike extent of disseminated gold mineralization [4][7] - The program aimed to expand the footprint of bulk-tonnage style mineralization and refine the geological and structural model for the target area [8][9] Key Findings - Drilling confirmed continuity of bulk-tonnage style gold mineralization over a 200-meter dip extent and at least a 100-meter strike extent, remaining open for further exploration [4][9] - Significant intersections included: - 10.4 meters of 0.54 g/t gold at 193.95 meters downhole in drill hole AW-25-010 - 12.77 meters of 0.77 g/t gold including 6.0 meters of 1.15 g/t gold at 331.8 meters downhole in the same hole [4][10] - 5.6 meters of 1.13 g/t gold at 92.45 meters downhole in drill hole AW-25-007 [4][10] Geological Context - The Aarnivalkea West target is located in a highly prospective area of the Central Lapland Greenstone Belt, with potential for both high-grade and disseminated mineralization [5][6] - The geological model indicates that gold mineralization is associated with quartz-carbonate-pyrite veins and broad zones of alteration in deformed volcanic rocks and diorite porphyries [6][8] Future Exploration Plans - Further drilling is warranted to explore the extent of the mineralization, particularly towards the southern Honka Zone, which is known for high-grade mineralization [4][11] - Results are pending from a Phase 1, 300-hole base of till program designed to identify high-priority drill targets across the Paana Project [12]

Core Viewpoint - Minera Alamos Inc. has successfully closed a private placement offering of C$3,500,000, issuing 8,750,000 Units at a price of C$0.40 per Unit, which includes common shares and purchase warrants [1] Group 1: Private Placement Details - The private placement involved the issuance of 8,750,000 Units, each consisting of one common share and one purchase warrant, with the warrants allowing the purchase of additional shares at C$0.705 for 36 months [1] - Executive Vice President, Corporate Development, Mr. Darren Blasutti, subscribed for 2,500,000 Units, contributing C$1,000,000 to the offering, which raised related party considerations under TSX Venture Exchange Policy 5.9 [2] - No finders fees were paid in connection with the placement, and all issued securities are subject to a hold period of four months and one day [3] Group 2: Financial Obligations and Settlements - The company plans to settle a contractual obligation of C$2,000,000 with an arm's length third party by issuing 4,651,163 shares at a price of C$0.43 per share, pending approval from the TSX Venture Exchange [4] Group 3: Company Overview - Minera Alamos is a North American gold production and development company, owning the Pan Operating Complex, which includes the Pan heap leach gold mine and the Gold Rock project, along with the Copperstone mine in Arizona [5] - The company has a portfolio of high-quality assets in Mexico, including the Santana open-pit mine and the Cerro de Oro oxide gold project, which is currently undergoing the permitting process [5] - The company aims to develop low capital expenditure assets while expanding resources and pursuing strategic acquisitions [5]

Core Viewpoint - Promino Nutritional Sciences Inc. is initiating a non-brokered private placement of secured convertible debentures, aiming to raise up to $1 million, with a potential increase to $1.5 million, to support its growth plans for 2026 [1][2]. Group 1: Offering Details - The offering consists of secured convertible debentures with a principal amount of $1,000 each, bearing an interest rate of 15% per annum, payable quarterly [2]. - The conversion price for the debentures is set at the greater of $0.05 or the five-day VWAP of the shares prior to the interest payment date [2]. - The offering is subject to approval from the Canadian Securities Exchange (CSE) and is expected to close around January 30, 2026 [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to accelerate growth through inventory investments and for general corporate purposes [3]. Group 3: Additional Securities - The company has granted 500,000 options to purchase shares at an exercise price of $0.05, with a maturity date of December 3, 2028, to a consultant [6]. Group 4: Company Overview - Promino Nutritional Sciences focuses on science-based nutrition for muscle health and recovery, with its core product being Rejuvenate Muscle Health™, a clinically researched amino acid formula [7]. - The company also produces Promino™, which is NSF Certified for Sport® and trusted by elite athletes [8].

Core Points - Q Precious & Battery Metals Corp. has successfully closed the fourth and final tranche of its private placement offering, which was oversubscribed [1][2]. Group 1: Offering Details - In the fourth tranche, the company issued 2,947,000 flow-through units at a price of $0.09 per unit, generating gross proceeds of $265,230 [2]. - Additionally, the company issued 2,222,222 flow-through shares at the same price, resulting in gross proceeds of $199,999.98 [3]. - The total gross amount received from this tranche is $465,229.98, with finder's fees amounting to $42,293 in cash, along with 234,961 finder's warrants and 187,969 compensation shares [3]. Group 2: Use of Proceeds - The proceeds from the offerings will be allocated to fund mineral exploration activities [4]. - The offering is subject to approval from the Canadian Securities Exchange, and the securities issued will have a statutory hold period of four months and one day from the issuance date [4].